Xeloda(R) Plus Avastin(R) Combination May Produce Clinical Benefit In Patients With Advanced Breast Cancer

... An interim analysis of the XCALIBr (Xeloda in Combination with Avastin as First-Line Treatment for HER2-Negative Metastatic Breast Cancer) trial suggested that first-line therapy with oral Xeloda(R) (capecitabine) in combination with Avastin(R) (bevacizumab) may offer clinical benefit in metastatic breast cancer patients who have no prior history of treatment. [click link for full article] ...